Calan sr and Synthroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calan sr (verapamil hydrochloride) and Synthroid (levothyroxine sodium). Common drug interactions include contusion among females and blindness unilateral among males.

The phase IV clinical study analyzes what interactions people have when they take Calan sr and Synthroid. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Calan sr?

Calan sr has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 589 Calan sr users. Check the latest studies of Calan sr.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,202 Synthroid users. Check the latest studies of Synthroid.



On Aug, 07, 2026

47 people who take Calan sr and Synthroid together, and have interactions are studied.

Calan sr and Synthroid drug interactions.

What are the common drug interactions of Calan Sr and Synthroid, by gender? *:

female:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Cough
  3. Dehydration (dryness resulting from the removal of water)
  4. Diplopia (double vision)
  5. Drug intolerance (drug sensitivity)
  6. Dry eye (lack of adequate tears)
  7. Dry skin
  8. Dry throat
  9. Dyspepsia (indigestion)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

male:

  1. Blindness unilateral
  2. Eye swelling
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  6. Dizziness
  7. Drug hypersensitivity
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Dyspnoea (difficult or laboured respiration)
  10. Essential hypertension (primary hypertension)

What are the common drug interactions of Calan Sr and Synthroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

30-39:

n/a

40-49:

  1. Oedema (fluid collection in tissue)
  2. Dizziness

50-59:

  1. Spinal fracture (fracture in one of vertebrae)
  2. Blood pressure decreased
  3. Confusion
  4. Confusional state
  5. Dizziness
  6. Dry mouth
  7. Fatigue (feeling of tiredness)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Tinnitus (a ringing in the ears)
  10. Vertigo

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Chest discomfort
  4. Crying
  5. Ear disorder
  6. Electrocardiogram st segment depression
  7. Loss of consciousness
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Nervousness
  10. Stress

What are the existing conditions these people have? *

  1. Thyroid Diseases: 11 people, 23.40%
  2. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 8 people, 17.02%
  3. Heart Rate Increased: 8 people, 17.02%
  4. Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 10.64%
  5. Pain: 4 people, 8.51%
  6. Multiple Myeloma (cancer of the plasma cells): 4 people, 8.51%
  7. Hypersensitivity: 4 people, 8.51%
  8. Arrhythmias (irregular heartbeat): 4 people, 8.51%
  9. Neoplasm Malignant (cancer tumour): 3 people, 6.38%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Calan sr and Synthroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Calan sr and Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Calan sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calan sr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synthroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on verapamil hydrochloride and levothyroxine sodium (the active ingredients of Calan sr and Synthroid, respectively), and Calan sr and Synthroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: